Recommended Dosage for Aspirin
Aspirin dosages vary by use. For cardiovascular prevention in adults at high risk (e.g., after heart attack or stroke), the standard low-dose is 75-100 mg once daily, often enteric-coated to reduce stomach irritation.[1] Higher doses like 325 mg daily apply for acute events or certain pain relief, but guidelines from the American Heart Association and American College of Cardiology recommend low-dose for long-term secondary prevention to minimize bleeding risk.[2]
Recommended Dosage for Vascepa
Vascepa (icosapent ethyl) treats high triglycerides in adults with levels ≥150 mg/dL plus cardiovascular disease or diabetes plus risk factors. The approved dose is 4 grams daily, taken as 2 grams (4 capsules of 0.5 grams each) twice daily with food to improve absorption and reduce gastrointestinal side effects.[3][4]
Using Aspirin and Vascepa Together
No specific combined dosage adjustment exists in labeling, but both increase bleeding risk—aspirin via platelet inhibition and Vascepa mildly via antiplatelet effects. Physicians often prescribe low-dose aspirin (81 mg daily) alongside Vascepa in cardiovascular patients, monitoring for bruising or bleeding. The REDUCE-IT trial, which supported Vascepa approval, allowed concurrent aspirin use at ≤325 mg/day without mandating changes.[5]
How Doctors Decide Dosages
Dosing depends on patient factors like weight, kidney function, bleeding history, and triglycerides. Aspirin starts low for prevention; Vascepa requires confirmed high triglycerides despite diet. Always follow prescribing information—over-the-counter aspirin needs medical guidance for heart use.[1][3]
Common Side Effects and Precautions
Aspirin: Stomach upset, ulcers, bleeding (especially with alcohol or NSAIDs). Vascepa: Muscle pain, rash, constipation; rare atrial fibrillation or bleeding. Avoid if allergic to fish (Vascepa source) or active peptic ulcer (aspirin).[3][6]
[1]: FDA Aspirin Label
[2]: AHA/ACC Guidelines
[3]: FDA Vascepa Label
[4]: Drugs.com Vascepa Dosing
[5]: NEJM REDUCE-IT Study
[6]: MedlinePlus Aspirin